Description of Business and Liquidity - Additional Information (Detail) - USD ($) $ in Thousands |
Dec. 18, 2019 |
Dec. 31, 2019 |
Dec. 17, 2019 |
Mar. 31, 2019 |
||
---|---|---|---|---|---|---|
Cash | $ 123,530 | $ 6,985 | ||||
Accumulated deficit | [1] | $ (70,675) | $ (24,838) | |||
Series A Preferred Stock [Member] | ||||||
Number of shares issued in business combination | 10,000 | |||||
Roivant Sciences Ltd. [Member] | Series A Preferred Stock [Member] | ||||||
Number of shares issued in business combination | 10,000 | |||||
Immunovant Sciences Ltd [Member] | ||||||
Percentage of business acquisition | 100.00% | |||||
Number of shares issued in business combination | 42,080,376 | |||||
Shares exchange ratio | 0.48907% | |||||
Immunovant Sciences Ltd [Member] | Sellers [Member] | ||||||
Ownership percentage | 100.00% | |||||
|
X | ||||||||||
- Definition Business combination shares exchange ratio. No definition available.
|
X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|